KGP-25
KGP-25 is a dual-targeting small molecule that inhibits the Nav1.8 sodium channel for peripheral analgesia and modulates GABAA receptors for CNS-mediated anesthesia. It is used in research to investigate pain pathways and anesthetic mechanisms in both in vitro and in vivo models.
Product Specifications
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog